Spectral Diagnostics (OTCMKTS:EDTXF) Shares Down 2% – Should You Sell?

by · The Cerbat Gem

Spectral Diagnostics Inc. (OTCMKTS:EDTXF – Get Free Report) shares were down 2% on Friday . The company traded as low as $0.8750 and last traded at $0.90. Approximately 9,700 shares were traded during trading, a decline of 41% from the average daily volume of 16,450 shares. The stock had previously closed at $0.9185.

Spectral Diagnostics Stock Performance

The stock has a 50 day moving average of $1.03 and a 200-day moving average of $0.84. The company has a market cap of $260.24 million, a PE ratio of -8.18 and a beta of 0.10.

Spectral Diagnostics (OTCMKTS:EDTXF – Get Free Report) last announced its quarterly earnings results on Friday, November 7th. The company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.07). The company had revenue of $0.49 million during the quarter, compared to the consensus estimate of $0.54 million.

Spectral Diagnostics Company Profile

(Get Free Report)

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.

See Also